St Vincent's Hospital, Sydney
Clinical trials sponsored by St Vincent's Hospital, Sydney, explained in plain language.
-
New drug shows promise in shrinking eye cancer before surgery
Disease control CompletedThis phase 2 trial tested the drug darovasertib in 15 people with high-risk uveal melanoma (a rare eye cancer) who were scheduled for eye removal surgery. Participants took the drug for up to 4 weeks before surgery, and some continued for 6 months afterward. The main goals were t…
Phase: PHASE2 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Tiny trial aims to shed light on PSMA scans in hard-to-treat prostate cancer
Knowledge-focused CompletedThis study tested whether taking dasatinib alone or with darolutamide for 14 days can increase PSMA levels on PET scans in men with metastatic prostate cancer. Only 4 men participated, all with low PSMA uptake on their initial scan. The goal was to learn more about how PSMA expre…
Phase: PHASE2 • Sponsor: St Vincent's Hospital, Sydney • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC